THE GLAUCOMA LAYER INSIDE EVERY PLAN.

Not a separate workflow — a screening layer that runs inside every RLES AI planning report: laser, phakic ICL and cataract/RLE alike. Thirteen rules, each checked against the current guideline and carrying its own open-access citation, watch the places where anterior-segment surgery and glaucoma genuinely intersect.

WHY A REFRACTIVE PLATFORM SCREENS FOR GLAUCOMA

Refractive candidates are young myopes, and myopia is an established risk factor for open-angle glaucoma. Ablation permanently thins the cornea, so applanation tonometry under-reads for life. And with the same field loss and progression rate, a young patient carries a far higher lifetime risk than an older one. The screening layer exists because these facts meet exactly where our patients stand.

WHAT THE THIRTEEN RULES WATCH

• The anterior chamber angle in every report — below 25° red, 25–30° amber, with gonioscopy as the primary assessment and seven additional risk factors queried when the angle is narrow^[2]
• Pigment dispersion findings before every phakic ICL — with the balance sentence the data supports, never a blanket claim
• Optic disc appearance without C/D fixation, and disc haemorrhage searched actively — OCT cannot image it, yet it strongly predicts progression^[1]
• The steroid period after surgery, including the interface-fluid trap that mimics DLK while demanding the opposite treatment
• Previous glaucoma surgery before any suction ring touches the eye — a filtering bleb and a pressure spike are a poor match^[7]
• The candidate on pressure-lowering drops: the dry-eye set becomes mandatory, because surface disease rises with every preserved drop^[5][6]

BEFORE A PHAKIC ICL

The ICL candidate pool and the glaucoma risk pool overlap more than anywhere else in refractive surgery. A borderline anterior chamber or a narrow angle sends the assessment back to gonioscopy — imaging complements it, never replaces it — and because an implanted lens measurably narrows the angle, the plan writes periodic angle follow-up into the aftercare. Angle closure in a young myope raises the plateau-iris question that a patent iridotomy alone does not settle. And pigment dispersion is actively screened before every implant — Krukenberg spindle, iris transillumination, heavily pigmented trabecular meshwork — with the balance the data supports: in the 629-eye EVO FDA three-year cohort, pigment dispersion and pupillary block were both zero^[9]. The rule is not "avoid the ICL"; it is "screen this exact population before the implant".

BEFORE CATARACT & RLE

The same layer runs in the cataract and refractive lens exchange module. Phacoemulsification alone lowers pressure modestly — around 12–15% in pooled analyses, an effect that fades after the second year — so the report never presents lens surgery as a way to control glaucoma^[10]. Clear-lens extraction has trial evidence only in patients aged fifty and over with high-risk angle closure; the system says so before anyone generalises it to a younger lens-exchange candidate^[11]. And when a post-refractive patient arrives for cataract surgery, the Refractive Passport supplies the pre-operative pressure and pachymetry that make a lifetime of under-reading tonometry interpretable.

POST-REFRACTIVE PRESSURE, HANDLED HONESTLY

After ablation, Goldmann tonometry under-reads — and no correction formula is validated enough to trust^[8]. The report says so plainly: biomechanically corrected tonometry first, context from the Refractive Passport second, and no "corrected" number ever presented as diagnostic. The Passport preserves the pre-operative pressure and pachymetry that this patient's glaucoma care will need decades from now.

THE REFERRAL SUMMARY

Whenever any of the thirteen rules fires, the report ends with a compact referral summary: the findings line by line with their bands, the suggested next steps — gonioscopy, fields, OCT, a glaucoma-specialist assessment — and a closing line that keeps the boundary honest: RLES AI does not diagnose glaucoma; the summary serves the surgeon's referral.

EDUCATION WITHOUT INDICATION

Ask the line anything — from trial protocols to surgical technique — and it answers with sourced study findings: trabeculectomy against drops in advanced disease^[3], tubes against trabeculectomy at five years^[4]. The single boundary never moves: the system educates the surgeon and never sets an indication for the patient.

See the layer at work: a full demonstration report on a fictitious case — tissue passes, six findings hold the plan. Download the demo report (PDF) →

FREQUENTLY ASKED QUESTIONS